Biotech Group Acquisition in an amended S-1 filing now plans to offer 7.5 million units, down from the 10 million initially registered with the SEC in April.
Each unit still consists of one share and a warrant, exercisable at $11.50.
The SPAC’s acquisition focus remains on the biotechnology sector in North America and the Asia-Pacific region (excluding China, Hong Kong and Macau).
Chairwoman and CEO Yiru (Melody) Shi has been CEO of YCM CPA, a registered public accounting firm, since 2020. Shi is also a Partner at North America CPA Alliance d/b/a MZ Tax and/or MZ Accounting & Tax Service, a public accounting and tax service company, a position she has held since September 2020.
The SPAC said it has applied to list on the Nasdaq under the symbol BGACU, with Tiger Brokers serving as lone book-runner. Read more.
